Topadur Pharma

News

8.10.20

Interview with Reto Naef, CEO of TOPADUR PHARMA AG

Read the full interview:

Download Document Dokument herunterladen Switzerland Global Enterprise Switzerland Global Enterprise

5.1.24

Press Release

Topadur Pharma AG receives an innosuisse grant

CHF 1.76 million is awarded from Innosuisse for the Phase 2a clinical trial with TOP-N53 in the treatment of digital ulcers

4.4.23

Press Release

TOPADUR appoints Pascal Brenneisen as Chief Executive Officer

TOPADUR announced that Pascal Brenneisen has been appointed CEO, effective April 1, 2023, on top of his Board member assignment.

8.10.20

News

Interview with Reto Naef, CEO of TOPADUR PHARMA AG

The Switzerland Global Enterprise interviewed Reto Naef, CEO of TOPADUR PHARMA AG.